F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Hot Fund

A91 Partners

a91partners.com · Mumbai, India

“Partners to enduring businesses for tomorrow's India. We back founders building category-leading companies across consumer, financial services, and technology, bringing the entire firm to every investment rather than a single partner.”

$10M – $50M
Check Size
Leads
Lead Tendency
$1.5B
AUM
01Investment Thesis

Partners to enduring businesses for tomorrow's India. We back founders building category-leading companies across consumer, financial services, and technology, bringing the entire firm to every investment rather than a single partner.

Exclusion Criteria

Not a purely global or non-India-linked technology strategy; generalist India growth-equity focus rather than a narrow sector specialist.

02Investment Team
AP
Abhay Pandey
General Partner
VB
VT Bharadwaj
General Partner
GM
Gautam Mago
General Partner
RK
Ruchi Khajanchi
CFO
KA
Kaushik Anand
Partner
PA
Prasun Agarwal
Partner
KS
Krunali Shah Pinjani
Investor
SA
Shivani Agarwal
Investor
PJ
Prathamesh Jain
Investor
AR
Ananga Rana
Investor
AV
Anooj Vikam
Investor
AS
Aakash Shankar
Investment Analyst
AS
Abhinav Singh
Investment Analyst
NS
Nesara S R
Investment Analyst
JT
John Tarun George
Investment Analyst
03F4 Research Brief

A91 Partners Research

Investment Thesis

A91 Partners is a Mumbai-based growth equity firm founded in 2018 by Abhay Pandey, VT Bharadwaj, and Gautam Mago, three investors who previously worked together at Sequoia Capital India. The firm's stated mission, drawn from its homepage, is to be "partners to enduring businesses for tomorrow's India." A91 backs founders building category-leading companies across consumer, financial services, software, and industrial technology, with a strong bias toward India-focused business models rather than global or purely technology-first plays. The firm describes its operating tenets as: speed matters, but velocity matters more; being patient and active partners; treating stewardship of capital as a differentiator; making commitments rather than bets; believing founders come in all forms with no single 'ideal' type; and bringing the entire firm, not just one partner, to every investment.

Sector Focus

A91's portfolio spans a wide range of sectors reflective of a generalist India growth-equity strategy: consumer and D2C brands (beauty, apparel, food and beverage), financial services and insurance, enterprise software and SaaS, logistics, and industrial/deep-tech manufacturing. Recent activity also shows an expansion into AI infrastructure and data services with its investment in Deccan AI, a US-based post-training data and evaluation startup serving frontier AI labs.

Stage Focus

A91 primarily invests at Series B and Series C, positioning itself as a growth-stage investor for companies that have already found product-market fit in India. Public reporting on Fund III (IFC's disclosure) describes typical commitments of $10M-$50M across roughly 15 portfolio companies, consistent with a concentrated, growth-stage strategy. The firm also does selective early-stage and pre-IPO/secondary transactions, as seen in its 2019 Series A lead in Atomberg and its 2026 follow-on into SUGAR Cosmetics ahead of a potential public listing.

Check Size

Typical check size is estimated at $10M-$50M based on Fund III's stated deployment plan (IFC disclosure), though the firm has also written smaller checks historically (e.g., its original 2019 Series A into Atomberg) and larger, board-level commitments in later rounds.

Recent Activity

A91 closed its third and largest fund, A91 Partners Trust III / A91 Emerging Fund III, at $665M in April 2025, pushing total AUM across its three funds past $1.5B. The firm has continued deploying actively into 2026: it led a $25M Series A in Deccan AI (announced March 2026), participated in a ₹144.5 crore follow-on round for existing portfolio company SUGAR Cosmetics (September 2026), and is a large selling shareholder (21% stake, largest shareholder) in Atomberg Technologies' 2026 IPO process, having led Atomberg's original Series A in 2019.

Portfolio Highlights

Notable current and past portfolio companies include Atomberg Technologies (smart appliances, now IPO-bound), SUGAR Cosmetics, Blue Tokai Coffee Roasters, Rare Rabbit, MoEngage, Exotel, Go Digit General Insurance, Niva Bupa Health Insurance, HealthKart, Inshorts, GIVA, DaMENSCH, Shipsy, Aye Finance, and Kaar Technologies, among roughly 30+ other consumer and enterprise businesses. A91 has backed several companies that have since pursued or completed public listings, including Go Digit and, pending, Atomberg.

Team

  • Abhay Pandey, General Partner — co-founder, previously at Sequoia Capital India
  • VT Bharadwaj, General Partner — co-founder, previously at Sequoia Capital India
  • Gautam Mago, General Partner — co-founder, previously at Sequoia Capital India
  • Ruchi Khajanchi, CFO
  • Kaushik Anand, Partner
  • Prasun Agarwal, Partner
  • Krunali Shah Pinjani, Investor
  • Shivani Agarwal, Investor
  • Prathamesh Jain, Investor
  • Ananga Rana, Investor
  • Anooj Vikam, Investor
  • Aakash Shankar, Investment Analyst
  • Abhinav Singh, Investment Analyst
  • Nesara S R, Investment Analyst
  • John Tarun George, Investment Analyst

Decision Process

A91 operates as a partnership of three General Partners plus a broader deal team of Partners, Investors, and Investment Analysts. The firm's stated culture ('bring the entire firm to every investment, not just an individual partner') suggests investment decisions are made collectively rather than by a solo GP.

Founder Preferences

A91 states that 'founders come in all forms, there is no ideal type,' suggesting an emphasis on business fundamentals and execution over founder pedigree. The portfolio shows a preference for founders building branded, category-defining consumer and financial-services businesses tailored to the Indian market, alongside technical founders in software and industrial technology.

Geographic Focus

A91 is squarely focused on India, with offices in Mumbai (Worli) and Gandhinagar, Gujarat (GIFT City). Its one notable exception is Deccan AI, a Bay Area-headquartered company with a India-based delivery workforce, reflecting some willingness to back founders with global platforms and India-linked operations.

04Selected Portfolio
Aerospace & Defense
Sasmos HET Technologies
Biotech & Life Sciences
Larenon
E-commerce & Marketplaces
Citykart·Rare Rabbit·TechnoSport·HealthKart·Plum·DaMensch·GIVA·Ninety One Cycles·Atomberg Technologies·SUGAR Cosmetics
Enterprise Software
Moengage·Kaar Technologies·Shipsy·Exotel·Deccan AI
Fintech & Payments
Finbox·Aye Finance
Food & Beverage
Shree Anandhaas·Akshayakalpa·Blue Tokai·Box8·Paree·Happilo·Push
Healthcare & Digital Health
Ummeed
HR Tech & Future of Work
Paper Boat
Insurance
Niva Bupa Health Insurance·Go Digit General Insurance
Manufacturing & Industrial
Sedemac
Media & Entertainment
Inshorts
Mobility & Transportation
IntrCity
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (5) →
Provided a ₹144.5 crore follow-on round to existing portfolio company SUGAR Cosmetics at a sharply reduced valuation.
INVESTMENT·moneycontrol.com
SEP 8, 2026
Portfolio company Atomberg Technologies filed draft IPO papers; A91 is Atomberg's largest shareholder (21.02% stake) and a selling shareholder in the offering, having led its 2019 Series A.
MILESTONE·yourstory.com+1
AUG 21, 2026
Led a $25M all-equity Series A in Deccan AI, a post-training data and model evaluation startup, with participation from Susquehanna and Prosus Ventures.
INVESTMENT·techcrunch.com+1
MAR 25, 2026
Received Venture Intelligence's VC Fund Raise of the Year 2025 award for closing its $665M third fund.
NEWS·linkedin.com
MAR 2026
Closed its third fund at $665M, its largest to date, pushing total firm AUM past $1.5B.
NEW FUND·m.economictimes.com+1
APR 22, 2025
06Frequent co-investors
FC
Faering Capital
Both backed 3 of the same companies
Niva Bupa Health Insurance, Go Digit General Insurance, Plum
EC
Elevation Capital
Both backed 2 of the same companies
Aye Finance, SUGAR Cosmetics
Find the investors for your round→
07Similar Firms
FC
Faering Capital
$10M – $50M · Series B · Series C
→
OV
OTP Ventures
$500K – $2M · Pre-Seed · Seed
→
IV
InfoEdge Ventures
$300K – $5M · Pre-Seed · Seed
→
SV
Stellaris Venture Partners
$500K – $10M · Pre-Seed · Seed
→
I
IndiaQuotient
$150K – $3M · Pre-Seed · Seed
→
Quick Reference
Check Size
$10M – $50M
Stages
Series B · Series C
AUM
$1.5B
Decision
Partnership
Warm Intro
Preferred
Involvement
Board Seat
Location
Mumbai, India
Sector Focus
Fintech & PaymentsManufacturing & IndustrialE-Commerce & MarketplacesInsuranceLogistics & Supply ChainMobility & TransportationEnterprise SoftwareFood & BeverageDeveloper Tools & InfrastructureMedia & Entertainment
Models
D2C Consumer BrandsFintechB2B SoftwareIndustrial Technology
Technology
AI/ML
See all Fintech & Payments investors →See all Manufacturing & Industrial investors →See all E-commerce & Marketplaces investors →
Visit a91partners.com ↗

See how A91 Partners matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Fintech & PaymentsManufacturing & IndustrialE-Commerce & MarketplacesInsuranceLogistics & Supply ChainMobility & TransportationEnterprise SoftwareFood & BeverageDeveloper Tools & InfrastructureMedia & Entertainment

See how A91 Partners matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched September 19, 2026F4 Research Engine